3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
20
Pancreatic Neoplasms
19
Carcinoma, Non-Small-Cell Lung
17
Ovarian Neoplasms
16
Fallopian Tube Neoplasms
12
Triple Negative Breast Neoplasms
10
Neoplasm Metastasis
10
Carcinoma, Ovarian Epithelial
10
Unspecified Adult Solid Tumor, Protocol Specific
8
Neoplasms
7
Lung Neoplasms
7
Endometrial Neoplasms
7
Esophageal Neoplasms
6
Brenner Tumor
6
Breast Neoplasms, Male
6
Stomach Neoplasms
5
Melanoma
5
Squamous Cell Carcinoma of Head and Neck
4
Peritoneal Neoplasms
3
Gallbladder Neoplasms
3
Cholangiocarcinoma
3
Adenocarcinoma of Lung
3
Adenocarcinoma
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Salivary Gland Neoplasms
2
Prostatic Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, Non-Hodgkin
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Interventions
tetulomab tetraxetan lu-177
2
osimertinib
2
fludarabine
2
entinostat
2
Pemetrexed
2
Lutetium
2
Carboplatin
2
spartalizumab
1
pembrolizumab
1
nirogacestat
1
interferon gamma-1b
1
gilteritinib
1
ficlatuzumab
1
emvododstat
1
denileukin diftitox
1
atezolizumab
1
Trabectedin
1
Taxes
1
Sunitinib
1
Radiosurgery
1
Oncolytic Virotherapy
1
Nivolumab
1
Lutetium-177
1
Interleukin-2
1
Interferon-gamma
1
Immunotherapy
1
Idarubicin
1
HuMax-IL8
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Granulocyte Colony-Stimulating Factor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Neoplasms by Histologic Type
×
Taxes
×
Clear all
NCT05494866
2025-03-25
IntenSify
German Cancer Research Center
Phase 1
Terminated
6 enrolled